Clinical Trial: Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801313) titled 'Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers' on Aug. 31.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, single-dose and multiple-dose, dose-escalation phase I clinical trial, aiming to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics, and immunogenicity of MWN105 injection in healthy Chinese volunteers, and to provide a reference for the next clinical trial.

This study includes a single ascending dose (SAD) study and a multiple ascending dose (MAD) study. The SAD study consists of 4 dose groups; the MAD study consists of 2 dose groups a...